An Indian company has plans to begin commercial production of a sweetener to rival Tate & Lyle’s sucralose brand Splenda in 14 months, according to a report today.
Pharmed Medicare president Sundeep Aurora told Dow Jones newswires that the company is currently making trial products. The plan is to produce 1,000 tonnes of the sweetener in its first phase in just over a year’s time.
He added that Pharmed is in talks with several possible customers globally.
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Just Food Excellence Awards - Have you nominated?
Nominations are now open for the prestigious Just Food Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!
Nominate Now
